S35– Elaboration of a topic prioritization instrument for the development of Clinical Practice Guidelines (CPGs) in Colombia

Abstract

and political organizations; 4) establishment of a national guideline bureau; 5) guideline adoption; 6) multidimensional dissemination; 7) structured implementation on regional level; 8) controlled evaluation study. RESULTS: A national guideline bureau was established by the German Medical Association in 2002. In 2003 the Association of the Scientific Medical Societies (n ϭ 153) and Association of Statutory Health Insurance Physicians (n ϭ 120,500) joined the program and consented on a guideline methodology. By now guidelines for asthma, COPD, CHD, diabetes, CHF, depression, and low back pain were developed and disseminated. Consumer involvement in development and implementation of DM CPGs started in 2005. First-generation DM CPGs are in the process (diabetes, CHD) or already finished updating (asthma). DISCUSSION (CONCLUSION): A countrywide disease management guideline program was established within 4 years. Until 2011, 12 DM CPGs will be finalized and implementation into quality management systems and regional care settings will be established. TARGET AUDIENCE(S): 1. Clinical researcher 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products 5. Quality improvement manager/facilitator 6. Health care policy analyst/policymaker 7. Health insurance payers and purchasers 8. Allied health professionals 9. Consumers' and patients' representatives S34-Development of revised recommendations for HIV counseling, testing, and linkage in nonhealth-care settings